BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 24450628)

  • 1. Regulation of IL-6-type cytokine responses by MAPKs.
    Costa-Pereira AP
    Biochem Soc Trans; 2014 Feb; 42(1):59-62. PubMed ID: 24450628
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Control of gp130 expression by the mitogen-activated protein kinase ERK2.
    Bonito NA; Drechsler J; Stoecker S; Carmo CR; Seckl MJ; Hermanns HM; Costa-Pereira AP
    Oncogene; 2014 Apr; 33(17):2255-63. PubMed ID: 23686311
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dynamics and non-canonical aspects of JAK/STAT signalling.
    Mohr A; Chatain N; Domoszlai T; Rinis N; Sommerauer M; Vogt M; Müller-Newen G
    Eur J Cell Biol; 2012; 91(6-7):524-32. PubMed ID: 22018664
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interleukin-6 promotes 2-deoxyglucose uptake through p44/42 MAPKs activation via Ca2+/PKC and EGF receptor in primary cultured chicken hepatocytes.
    Suh HN; Lee YJ; Han HJ
    J Cell Physiol; 2009 Mar; 218(3):643-52. PubMed ID: 19006119
    [TBL] [Abstract][Full Text] [Related]  

  • 5. gp130 and the IL-6 family of cytokines: signaling mechanisms and thrombopoietic activities.
    Nakashima K; Taga T
    Semin Hematol; 1998 Jul; 35(3):210-21. PubMed ID: 9685167
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cross-regulation of cytokine signalling: pro-inflammatory cytokines restrict IL-6 signalling through receptor internalisation and degradation.
    Radtke S; Wüller S; Yang XP; Lippok BE; Mütze B; Mais C; de Leur HS; Bode JG; Gaestel M; Heinrich PC; Behrmann I; Schaper F; Hermanns HM
    J Cell Sci; 2010 Mar; 123(Pt 6):947-59. PubMed ID: 20200229
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Jak/STAT and PI3K signaling pathways have both common and distinct roles in IL-7-mediated activities in human CD8+ T cells.
    Crawley AM; Vranjkovic A; Faller E; McGuinty M; Busca A; Burke SC; Cousineau S; Kumar A; Macpherson PA; Angel JB
    J Leukoc Biol; 2014 Jan; 95(1):117-27. PubMed ID: 24072878
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Model-driven experimental analysis of the function of SHP-2 in IL-6-induced Jak/STAT signaling.
    Dittrich A; Quaiser T; Khouri C; Görtz D; Mönnigmann M; Schaper F
    Mol Biosyst; 2012 Aug; 8(8):2119-34. PubMed ID: 22711165
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Leukemia inhibitory factor regulates differentiation of trophoblastlike BeWo cells through the activation of JAK/STAT and MAPK3/1 MAP kinase-signaling pathways.
    Leduc K; Bourassa V; Asselin E; Leclerc P; Lafond J; Reyes-Moreno C
    Biol Reprod; 2012 Feb; 86(2):54. PubMed ID: 22053093
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin-like growth factor-I receptor signal transduction and the Janus Kinase/Signal Transducer and Activator of Transcription (JAK-STAT) pathway.
    Himpe E; Kooijman R
    Biofactors; 2009; 35(1):76-81. PubMed ID: 19319849
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel type-1 cytokine receptor from fish involved in the Janus kinase/signal transducers and activators of transcription (Jak/STAT) signal pathway.
    Santos MD; Yasuike M; Kondo H; Hirono I; Aoki T
    Mol Immunol; 2007 Jul; 44(13):3355-63. PubMed ID: 17383728
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rho family GTPase inhibition reveals opposing effects of mitogen-activated protein kinase kinase/extracellular signal-regulated kinase and Janus kinase/signal transducer and activator of transcription signaling cascades on neuronal survival.
    Loucks FA; Le SS; Zimmermann AK; Ryan KR; Barth H; Aktories K; Linseman DA
    J Neurochem; 2006 May; 97(4):957-67. PubMed ID: 16686690
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glycoprotein 130 cytokine signal as a therapeutic target against cardiovascular diseases.
    Fujio Y; Maeda M; Mohri T; Obana M; Iwakura T; Hayama A; Yamashita T; Nakayama H; Azuma J
    J Pharmacol Sci; 2011; 117(4):213-22. PubMed ID: 22056652
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Matrix metalloproteinase-13 expression in IL-1β-treated chondrocytes by activation of the p38 MAPK/c-Fos/AP-1 and JAK/STAT pathways.
    Lim H; Kim HP
    Arch Pharm Res; 2011 Jan; 34(1):109-17. PubMed ID: 21468922
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Jaks and cytokine receptors--an intimate relationship.
    Haan C; Kreis S; Margue C; Behrmann I
    Biochem Pharmacol; 2006 Nov; 72(11):1538-46. PubMed ID: 16750817
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activated Rac1 requires gp130 for Stat3 activation, cell proliferation and migration.
    Arulanandam R; Geletu M; Feracci H; Raptis L
    Exp Cell Res; 2010 Mar; 316(5):875-86. PubMed ID: 19852956
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IL-6 signal transduction and its physiological roles: the signal orchestration model.
    Kamimura D; Ishihara K; Hirano T
    Rev Physiol Biochem Pharmacol; 2003; 149():1-38. PubMed ID: 12687404
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interleukin-6 and interleukin-11: same same but different.
    Garbers C; Scheller J
    Biol Chem; 2013 Sep; 394(9):1145-61. PubMed ID: 23740659
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IL-6/IL-6 receptor system and its role in physiological and pathological conditions.
    Mihara M; Hashizume M; Yoshida H; Suzuki M; Shiina M
    Clin Sci (Lond); 2012 Feb; 122(4):143-59. PubMed ID: 22029668
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Principles of interleukin (IL)-6-type cytokine signalling and its regulation.
    Heinrich PC; Behrmann I; Haan S; Hermanns HM; Müller-Newen G; Schaper F
    Biochem J; 2003 Aug; 374(Pt 1):1-20. PubMed ID: 12773095
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.